Search results
Metis Global Partners LLC Sells 549 Shares of Incyte Co. (NASDAQ:INCY)
ETF DAILY NEWS· 6 days agoMetis Global Partners LLC lessened its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 6.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned ...
Brokerages Set Incyte Co. (NASDAQ:INCY) PT at $74.93
ETF DAILY NEWS· 6 days agoIncyte Co. (NASDAQ:INCY – Get Free Report) has been given an average recommendation of “Hold” by the seventeen research firms that are covering the company, Marketbeat reports. Nine equities ...
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 2 days agoRecent news from the Company's two clinical programs includes: A heavily pretreated breast cancer patient, enrolled in the ALG...its upcoming dose optimization trial in 2Q ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoVincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug conjugate (SMDC) The National Institutes of Health
FY2026 EPS Estimates for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Reduced by HC Wainwright
ETF DAILY NEWS· 3 days agoRigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities researchers at HC Wainwright cut their FY2026 EPS estimates for Rigel Pharmaceuticals in a research report issued on Wednesday ...
Research Analysts Offer Predictions for Vor Biopharma Inc.’s FY2028 Earnings (NYSE:VOR)
ETF DAILY NEWS· 3 days agoVor Biopharma Inc. (NYSE:VOR – Free Report) – Stock analysts at HC Wainwright decreased their FY2028 earnings estimates for Vor Biopharma in a report released on Friday, May 10th. HC Wainwright ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...
Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's...
Digital Journal· 3 days agoSTONY BROOK, NY / ACCESSWIRE / May 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, and the Institute of Hematology and Blood Transfusion ...
